biotech
US To Acquire Anthrax Drug From Cangene
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on July 28, 2006
2004 Complete Guide to Biological Weapons and Terrorism, Anthrax, Smallpox, Monkeypox, Ricin, Botulism, Brucellosis, Toxins, Plague, Q Fever, Tularemia, ... WMD, First Responder Two CD-ROM Set)
In June the US government has agreed to purchase 20,000 doses of ABthraxâ„¢ from Human Genome Sciences. But the stockpiling of drugs against inhalational anthrax, a potential bioweapon causing an acute infectious disease resulting from inhaling spores of Bacillus anthracis, is not yet over. Still under the Project BioShield Act of 2004, the U.S. Department of Health and Human Services will acquire an additional 10,000 doses of anthrax immune globulin (AIG) for $143 million, this time from Cangene.

More information about AIG and the supply contract from Cangene's press release.


Permalink: US To Acquire Anthrax Drug From Cangene
Tags: anthrax  bioweapon  biotech  cangene  acquire  acquire+anthrax  anthrax+drug  stem+cells 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/30500
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for US To Acquire Anthrax Drug From Cangene:

  • Currently 8.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.67 out of 3 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!